Total Payments
$3,099
2024 Payments
$626.45
Companies
16
Transactions
162
Medicare Patients
1,984
Medicare Billing
$326,060
Payment Breakdown by Category
Food & Beverage$3,099 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,099 | 162 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $579.96 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $447.59 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $428.44 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $321.65 | 18 | $0 (2024) |
| ABIOMED | $265.79 | 13 | $0 (2024) |
| PFIZER INC. | $252.91 | 14 | $0 (2022) |
| Shionogi Inc | $247.56 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.38 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $106.42 | 5 | $0 (2023) |
| ABBVIE INC. | $51.86 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $626.45 | 31 | Janssen Pharmaceuticals, Inc ($200.63) |
| 2023 | $999.81 | 49 | Merck Sharp & Dohme LLC ($186.12) |
| 2022 | $646.43 | 35 | Novartis Pharmaceuticals Corporation ($189.49) |
| 2021 | $469.23 | 27 | PFIZER INC. ($135.61) |
| 2020 | $306.97 | 17 | Janssen Pharmaceuticals, Inc ($132.48) |
| 2019 | $50.02 | 3 | Merck Sharp & Dohme Corporation ($50.02) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: COVID-19 | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Cardiovascular | ||||||
| 07/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Cardiovascular | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: DIABETES | ||||||
| 05/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: DIABETES | ||||||
| 03/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 476 | 940 | $181,320 | $78,953 |
| 2022 | 11 | 504 | 1,045 | $197,200 | $80,646 |
| 2021 | 9 | 504 | 1,057 | $208,415 | $88,245 |
| 2020 | 9 | 500 | 916 | $180,040 | $78,216 |
Total Patients
1,984
Total Services
3,958
Medicare Billing
$326,060
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 448 | $67,200 | $29,420 | 43.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 83 | 227 | $47,670 | $22,531 | 47.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 141 | 148 | $31,080 | $13,805 | 44.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 57 | $22,230 | $8,282 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $9,805 | $3,346 | 34.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 23 | $3,335 | $1,569 | 47.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 142 | 515 | $77,250 | $30,696 | 39.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 251 | $52,710 | $21,294 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 90 | 95 | $19,950 | $8,418 | 42.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $10,710 | $5,048 | 47.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $8,100 | $3,912 | 48.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 23 | $8,970 | $3,406 | 38.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 12 | $5,460 | $2,196 | 40.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $5,300 | $2,143 | 40.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 26 | 26 | $3,770 | $1,586 | 42.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 20 | 20 | $2,900 | $1,224 | 42.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,080 | $721.98 | 34.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 102 | 383 | $80,430 | $33,679 | 41.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 105 | 366 | $54,900 | $22,158 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 111 | 118 | $24,780 | $10,830 | 43.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 35 | $13,650 | $5,753 | 42.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 38 | 38 | $11,970 | $5,534 | 46.2% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 42 | 43 | $9,675 | $4,656 | 48.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 41 | 44 | $6,380 | $2,741 | 43.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $5,035 | $2,208 | 43.9% |
About John Mense
John Mense is a Internal Medicine healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1588051171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Mense has received a total of $3,099 in payments from pharmaceutical and medical device companies, with $626.45 received in 2024. These payments were reported across 162 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,099).
As a Medicare-enrolled provider, Mense has provided services to 1,984 Medicare beneficiaries, totaling 3,958 services with total Medicare billing of $326,060. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Torrance, CA
- Active Since 04/21/2015
- Last Updated 03/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588051171
Products in Payments
- XARELTO (Drug) $579.96
- ELIQUIS (Drug) $492.31
- ENTRESTO (Drug) $365.83
- Impella (Device) $265.79
- Fetroja (Drug) $247.56
- JARDIANCE (Drug) $172.17
- DIFICID (Drug) $157.72
- CAMZYOS (Drug) $153.45
- XIFAXAN (Drug) $106.42
- ZERBAXA (Drug) $66.60
- LEQVIO (Drug) $62.61
- LOKELMA (Drug) $47.84
- DALVANCE (Drug) $37.02
- NEPHROCHECK LIQUID CONTROL KIT (Device) $27.52
- SPIRIVA RESPIMAT (Drug) $26.75
- JYNARQUE (Drug) $23.68
- VYNDAQEL (Drug) $23.22
- VOWST (Biological) $22.77
- STIOLTO RESPIMAT (Drug) $22.34
- Veklury (Drug) $19.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Torrance
Catherine Oberg, M.d, M.D
Internal Medicine — Payments: $307,633
Internal Medicine $307,633
Dr. Robert Jenders
Internal Medicine — Payments: $158,314
Internal Medicine $158,314
Vivek Gupta, M.d, M.D
Internal Medicine — Payments: $47,609
Internal Medicine $47,609
Dr. Sofiya Reicher, Md, MD
Internal Medicine — Payments: $41,778
Internal Medicine $41,778
Dr. Zonglang Tsai, M.d, M.D
Internal Medicine — Payments: $29,124
Internal Medicine $29,124
Khalid Eltawil, Md, MD
Internal Medicine — Payments: $25,608
Internal Medicine $25,608